【结 构 式】 |
【药物名称】S-35031 【化学名称】3-[6-(4-Chlorophenylsulfonamido)-3-[2-(4-methylpiperazin-1-yl)phenoxymethyl]-5,6,7,8-tetrahydronaphthalen-1-yl]propionic acid 【CA登记号】 【 分 子 式 】C31H36ClN3O5S 【 分 子 量 】598.16667 |
【开发单位】Servier (Originator) 【药理作用】Antiplatelet Therapy, CARDIOVASCULAR DRUGS, Coagulation Disorders Therapy, HEMATOLOGIC DRUGS, Hypertension, Treatment of, 5-HT2A Antagonists, Prostanoid TP (Thromboxane A2) Antagonists |
合成路线1
Bromination of the coumarin derivative (I) with Br2 in DMF afforded the bromo coumarin (II). Diels-Alder cycloaddition between bromo coumarin (II) and ethyl 3-(trimethylsilyl)propiolate (III) with concomitant decarboxylation furnished the tetrahydronaphthalene (IV). After desilylation of (IV) with trifluoroacetic acid, the resultant ester (V) was reduced to alcohol (VI) using the combination LiAlH4-AlCl3. Further oxidation of the alcohol function of (VI) to aldehyde (VII) was performed with 4-benzylpyridinium dichromate (BPDC) in CH2Cl2. Wittig reaction of aldehyde (VII) with methyl (triphenylphosphoranylidene)acetate produced the arylacrylate ester (VIII), which was then reduced to the saturated ester (IX) employing NaBH4 in the presence of CoCl2.
【1】 Cimetiere, B.; et al.; Discovery of new combined 5-HT2 and TP-receptor antagonists. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 57. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 19586 | 4-chloro-N-(2-oxo-5,6,7,8-tetrahydro-2H-chromen-6-yl)benzenesulfonamide | C15H14ClNO4S | 详情 | 详情 | |
(II) | 19587 | N-(3-bromo-2-oxo-5,6,7,8-tetrahydro-2H-chromen-6-yl)-4-chlorobenzenesulfonamide | C15H13BrClNO4S | 详情 | 详情 | |
(III) | 23898 | ethyl 3-(trimethylsilyl)-2-propynoate | 29394-58-9 | C8H14O2Si | 详情 | 详情 |
(IV) | 49920 | ethyl 3-bromo-6-[[(4-chlorophenyl)sulfonyl]amino]-2-(trimethylsilyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxylate | C22H27BrClNO4SSi | 详情 | 详情 | |
(V) | 49921 | ethyl 3-bromo-6-[[(4-chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-1-naphthalenecarboxylate | C19H19BrClNO4S | 详情 | 详情 | |
(VI) | 19590 | N-[7-bromo-5-(hydroxymethyl)-1,2,3,4-tetrahydro-2-naphthalenyl]-4-chlorobenzenesulfonamide | C17H17BrClNO3S | 详情 | 详情 | |
(VII) | 19591 | N-(7-bromo-5-formyl-1,2,3,4-tetrahydro-2-naphthalenyl)-4-chlorobenzenesulfonamide | C17H15BrClNO3S | 详情 | 详情 | |
(VIII) | 49922 | methyl (E)-3-(3-bromo-6-[[(4-chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-1-naphthalenyl)-2-propenoate | C20H19BrClNO4S | 详情 | 详情 | |
(IX) | 49923 | methyl 3-(3-bromo-6-[[(4-chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-1-naphthalenyl)propanoate | C20H21BrClNO4S | 详情 | 详情 |
合成路线2
Heck reaction of aryl bromide (IX) with vinyl tributyltin (X) in the presence of palladium catalyst gave the vinyl tetrahydronaphthalene (XI), which was subjected to oxidative double-bond cleavage to aldehyde (XII) using NaIO4 in the presence of a catalytic amount of OsO4. Aldehyde reduction with NaBH4 provided alcohol (XIII). This was then converted to the corresponding bromide (XIV) by treatment with carbon tetrabromide and triphenylphosphine.
【1】 Cimetiere, B.; et al.; Discovery of new combined 5-HT2 and TP-receptor antagonists. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 57. |
【2】 Verbeuren, T.; Simonet, S.; Descombes, J.-J.; Cimetiere, B.; Lavielle, G. (ADIR et Cie.); Benzenesulfonamide derivs., process for their preparation and pharmaceutical compsns. containing them. EP 1118610; FR 2803848; JP 2001226353 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IX) | 49923 | methyl 3-(3-bromo-6-[[(4-chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-1-naphthalenyl)propanoate | C20H21BrClNO4S | 详情 | 详情 | |
(X) | 24920 | tributyl(vinyl)stannane;Tributylvinylstannane;Vinyltributylstannane | 7486-35-3 | C14H30Sn | 详情 | 详情 |
(XI) | 49924 | methyl 3-(6-[[(4-chlorophenyl)sulfonyl]amino]-3-vinyl-5,6,7,8-tetrahydro-1-naphthalenyl)propanoate | C22H24ClNO4S | 详情 | 详情 | |
(XII) | 49925 | methyl 3-(6-[[(4-chlorophenyl)sulfonyl]amino]-3-formyl-5,6,7,8-tetrahydro-1-naphthalenyl)propanoate | C21H22ClNO5S | 详情 | 详情 | |
(XIII) | 49926 | methyl 3-[6-[[(4-chlorophenyl)sulfonyl]amino]-3-(hydroxymethyl)-5,6,7,8-tetrahydro-1-naphthalenyl]propanoate | C21H24ClNO5S | 详情 | 详情 | |
(XIV) | 49927 | methyl 3-(3-(bromomethyl)-6-[[(4-chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-1-naphthalenyl)propanoate | C21H23BrClNO4S | 详情 | 详情 |
合成路线3
Acylation of 2-(1-piperazinyl)phenol (XV) with ethyl chloroformate produced the carbamate (XVI). After protection of the phenolic hydroxyl of (XVI) as the corresponding tosylate (XVII), reduction of the carbamate group of (XVII) with LiAlH4 gave rise to the N-methylpiperazine (XVIII). The tosylate group of (XVIII) was then removed by hydrolysis with KOH in aqueous ethanol, yielding phenol (XIX). The Williamson's ether synthesis between phenol (XIX) and bromide (XIV) provided adduct (XX). Finally, basic hydrolysis of the ester group of (XX) furnished the title carboxylic acid
【1】 Cimetiere, B.; et al.; Discovery of new combined 5-HT2 and TP-receptor antagonists. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 57. |
【2】 Verbeuren, T.; Simonet, S.; Descombes, J.-J.; Cimetiere, B.; Lavielle, G. (ADIR et Cie.); Benzenesulfonamide derivs., process for their preparation and pharmaceutical compsns. containing them. EP 1118610; FR 2803848; JP 2001226353 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XIV) | 49927 | methyl 3-(3-(bromomethyl)-6-[[(4-chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-1-naphthalenyl)propanoate | C21H23BrClNO4S | 详情 | 详情 | |
(XV) | 49928 | 2-(1-piperazinyl)phenol | C10H14N2O | 详情 | 详情 | |
(XVI) | 49929 | ethyl 4-(2-hydroxyphenyl)-1-piperazinecarboxylate | C13H18N2O3 | 详情 | 详情 | |
(XVII) | 49930 | ethyl 4-(2-[[(4-methylphenyl)sulfonyl]oxy]phenyl)-1-piperazinecarboxylate | C20H24N2O5S | 详情 | 详情 | |
(XVIII) | 49931 | 2-(4-methyl-1-piperazinyl)phenyl 4-methylbenzenesulfonate | C18H22N2O3S | 详情 | 详情 | |
(XIX) | 49932 | 2-(4-methyl-1-piperazinyl)phenol | C11H16N2O | 详情 | 详情 | |
(XX) | 49933 | methyl 3-(6-[[(4-chlorophenyl)sulfonyl]amino]-3-[[2-(4-methyl-1-piperazinyl)phenoxy]methyl]-5,6,7,8-tetrahydro-1-naphthalenyl)propanoate | C32H38ClN3O5S | 详情 | 详情 |